 | • レポートコード：MRC2102QY2167 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、142ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥592,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥888,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,184,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界の乳がん治療薬市場について種類別（有糸分裂阻害剤、代謝拮抗剤、ホルモン受容体、アロマターゼ阻害剤、HER2阻害剤）、用途別（フェーズI、フェーズII、フェーズIII）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・乳がん治療薬市場の概要 ・世界の主要地域別乳がん治療薬市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の乳がん治療薬市場規模2015-2026：種類別（有糸分裂阻害剤、代謝拮抗剤、ホルモン受容体、アロマターゼ阻害剤、HER2阻害剤） ・世界の乳がん治療薬市場規模2015-2026：用途別（フェーズI、フェーズII、フェーズIII） ・乳がん治療薬の米国市場規模2015-2020 ・乳がん治療薬のヨーロッパ市場規模2015-2020 ・乳がん治療薬の中国市場規模2015-2020 ・乳がん治療薬の日本市場規模2015-2020 ・乳がん治療薬の東南アジア市場規模2015-2020 ・乳がん治療薬のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・乳がん治療薬の製造コスト分析 ・販売チャネル、流通業者、顧客 ・乳がん治療薬の市場動向・機会・課題 ・調査の結論 |
Medicines include tamoxifen (Nolvadex) for women before and after menopause and aromatase inhibitors including anastrozole (Arimidex), exemestane (Aromasin), and letrozole (Femara) for postmenopausal women. Side effects can include hot flashes and vaginal dryness
Market Analysis and Insights: Global Breast Cancer Therapeutics Drugs Market
The global Breast Cancer Therapeutics Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Breast Cancer Therapeutics Drugs Scope and Market Size
The global Breast Cancer Therapeutics Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Breast Cancer Therapeutics Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Breast Cancer Therapeutics Drugs market is segmented into
Mitotic Inhibitors
Anti-Metabolites
Hormone Receptor
Aromatase Inhibitors
HER2 Inhibitors
Segment by Application, the Breast Cancer Therapeutics Drugs market is segmented into
Phase I
Phase II
Phase III
The Breast Cancer Therapeutics Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Breast Cancer Therapeutics Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Breast Cancer Therapeutics Drugs Market Share Analysis
Breast Cancer Therapeutics Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Breast Cancer Therapeutics Drugs business, the date to enter into the Breast Cancer Therapeutics Drugs market, Breast Cancer Therapeutics Drugs product introduction, recent developments, etc.
The major vendors covered:
Bayer HealthCare
Eli Lily
Pfizer
Novartis
Eisai
Halozyme Therapeutics
Roche
Puma Biotechnology
Janssen Biotech
AbbVie
BioMarin
Array BioPharma
Merck
Syndax
MacroGenics
ImmunoGen
Santen Pharma
Celgene
Oncothyreon
AstraZeneca
Sprint Bioscience
Genentech
Galena Biopharma
Lycera
CTI BioPharma
1 Breast Cancer Therapeutics Drugs Market Overview
1.1 Breast Cancer Therapeutics Drugs Product Scope
1.2 Breast Cancer Therapeutics Drugs Segment by Type
1.2.1 Global Breast Cancer Therapeutics Drugs Sales by Type (2020-2026)
1.2.2 Mitotic Inhibitors
1.2.3 Anti-Metabolites
1.2.4 Hormone Receptor
1.2.5 Aromatase Inhibitors
1.2.6 HER2 Inhibitors
1.3 Breast Cancer Therapeutics Drugs Segment by Application
1.3.1 Global Breast Cancer Therapeutics Drugs Sales Comparison by Application (2020-2026)
1.3.2 Phase I
1.3.3 Phase II
1.3.4 Phase III
1.4 Breast Cancer Therapeutics Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Breast Cancer Therapeutics Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Breast Cancer Therapeutics Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Breast Cancer Therapeutics Drugs Price Trends (2015-2026)
2 Breast Cancer Therapeutics Drugs Estimate and Forecast by Region
2.1 Global Breast Cancer Therapeutics Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Breast Cancer Therapeutics Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Breast Cancer Therapeutics Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Breast Cancer Therapeutics Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Breast Cancer Therapeutics Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Breast Cancer Therapeutics Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Breast Cancer Therapeutics Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Breast Cancer Therapeutics Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Breast Cancer Therapeutics Drugs Estimates and Projections (2015-2026)
2.4.3 China Breast Cancer Therapeutics Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Breast Cancer Therapeutics Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Breast Cancer Therapeutics Drugs Estimates and Projections (2015-2026)
2.4.6 India Breast Cancer Therapeutics Drugs Estimates and Projections (2015-2026)
3 Global Breast Cancer Therapeutics Drugs Competition Landscape by Players
3.1 Global Top Breast Cancer Therapeutics Drugs Players by Sales (2015-2020)
3.2 Global Top Breast Cancer Therapeutics Drugs Players by Revenue (2015-2020)
3.3 Global Breast Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Therapeutics Drugs as of 2019)
3.4 Global Breast Cancer Therapeutics Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Breast Cancer Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Breast Cancer Therapeutics Drugs Players (Opinion Leaders)
4 Global Breast Cancer Therapeutics Drugs Market Size by Type
4.1 Global Breast Cancer Therapeutics Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Breast Cancer Therapeutics Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Breast Cancer Therapeutics Drugs Price by Type (2015-2020)
4.2 Global Breast Cancer Therapeutics Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Breast Cancer Therapeutics Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Breast Cancer Therapeutics Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Breast Cancer Therapeutics Drugs Price Forecast by Type (2021-2026)
5 Global Breast Cancer Therapeutics Drugs Market Size by Application
5.1 Global Breast Cancer Therapeutics Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Breast Cancer Therapeutics Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Breast Cancer Therapeutics Drugs Price by Application (2015-2020)
5.2 Global Breast Cancer Therapeutics Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Breast Cancer Therapeutics Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Breast Cancer Therapeutics Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Breast Cancer Therapeutics Drugs Price Forecast by Application (2021-2026)
6 United States Breast Cancer Therapeutics Drugs Market Facts & Figures
6.1 United States Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
6.2 United States Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
6.3 United States Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
7 Europe Breast Cancer Therapeutics Drugs Market Facts & Figures
7.1 Europe Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
8 China Breast Cancer Therapeutics Drugs Market Facts & Figures
8.1 China Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
8.2 China Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
8.3 China Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
9 Japan Breast Cancer Therapeutics Drugs Market Facts & Figures
9.1 Japan Breast Cancer Therapeutics Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
10 Southeast Asia Breast Cancer Therapeutics Drugs Market Facts & Figures
10.1 Southeast Asia Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
11 India Breast Cancer Therapeutics Drugs Market Facts & Figures
11.1 India Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
11.2 India Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
11.3 India Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Breast Cancer Therapeutics Drugs Business
12.1 Bayer HealthCare
12.1.1 Bayer HealthCare Corporation Information
12.1.2 Bayer HealthCare Business Overview
12.1.3 Bayer HealthCare Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Bayer HealthCare Breast Cancer Therapeutics Drugs Products Offered
12.1.5 Bayer HealthCare Recent Development
12.2 Eli Lily
12.2.1 Eli Lily Corporation Information
12.2.2 Eli Lily Business Overview
12.2.3 Eli Lily Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Eli Lily Breast Cancer Therapeutics Drugs Products Offered
12.2.5 Eli Lily Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Breast Cancer Therapeutics Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Breast Cancer Therapeutics Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Eisai
12.5.1 Eisai Corporation Information
12.5.2 Eisai Business Overview
12.5.3 Eisai Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Eisai Breast Cancer Therapeutics Drugs Products Offered
12.5.5 Eisai Recent Development
12.6 Halozyme Therapeutics
12.6.1 Halozyme Therapeutics Corporation Information
12.6.2 Halozyme Therapeutics Business Overview
12.6.3 Halozyme Therapeutics Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Halozyme Therapeutics Breast Cancer Therapeutics Drugs Products Offered
12.6.5 Halozyme Therapeutics Recent Development
12.7 Roche
12.7.1 Roche Corporation Information
12.7.2 Roche Business Overview
12.7.3 Roche Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Roche Breast Cancer Therapeutics Drugs Products Offered
12.7.5 Roche Recent Development
12.8 Puma Biotechnology
12.8.1 Puma Biotechnology Corporation Information
12.8.2 Puma Biotechnology Business Overview
12.8.3 Puma Biotechnology Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Puma Biotechnology Breast Cancer Therapeutics Drugs Products Offered
12.8.5 Puma Biotechnology Recent Development
12.9 Janssen Biotech
12.9.1 Janssen Biotech Corporation Information
12.9.2 Janssen Biotech Business Overview
12.9.3 Janssen Biotech Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Janssen Biotech Breast Cancer Therapeutics Drugs Products Offered
12.9.5 Janssen Biotech Recent Development
12.10 AbbVie
12.10.1 AbbVie Corporation Information
12.10.2 AbbVie Business Overview
12.10.3 AbbVie Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.10.4 AbbVie Breast Cancer Therapeutics Drugs Products Offered
12.10.5 AbbVie Recent Development
12.11 BioMarin
12.11.1 BioMarin Corporation Information
12.11.2 BioMarin Business Overview
12.11.3 BioMarin Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.11.4 BioMarin Breast Cancer Therapeutics Drugs Products Offered
12.11.5 BioMarin Recent Development
12.12 Array BioPharma
12.12.1 Array BioPharma Corporation Information
12.12.2 Array BioPharma Business Overview
12.12.3 Array BioPharma Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Array BioPharma Breast Cancer Therapeutics Drugs Products Offered
12.12.5 Array BioPharma Recent Development
12.13 Merck
12.13.1 Merck Corporation Information
12.13.2 Merck Business Overview
12.13.3 Merck Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Merck Breast Cancer Therapeutics Drugs Products Offered
12.13.5 Merck Recent Development
12.14 Syndax
12.14.1 Syndax Corporation Information
12.14.2 Syndax Business Overview
12.14.3 Syndax Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Syndax Breast Cancer Therapeutics Drugs Products Offered
12.14.5 Syndax Recent Development
12.15 MacroGenics
12.15.1 MacroGenics Corporation Information
12.15.2 MacroGenics Business Overview
12.15.3 MacroGenics Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.15.4 MacroGenics Breast Cancer Therapeutics Drugs Products Offered
12.15.5 MacroGenics Recent Development
12.16 ImmunoGen
12.16.1 ImmunoGen Corporation Information
12.16.2 ImmunoGen Business Overview
12.16.3 ImmunoGen Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.16.4 ImmunoGen Breast Cancer Therapeutics Drugs Products Offered
12.16.5 ImmunoGen Recent Development
12.17 Santen Pharma
12.17.1 Santen Pharma Corporation Information
12.17.2 Santen Pharma Business Overview
12.17.3 Santen Pharma Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.17.4 Santen Pharma Breast Cancer Therapeutics Drugs Products Offered
12.17.5 Santen Pharma Recent Development
12.18 Celgene
12.18.1 Celgene Corporation Information
12.18.2 Celgene Business Overview
12.18.3 Celgene Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.18.4 Celgene Breast Cancer Therapeutics Drugs Products Offered
12.18.5 Celgene Recent Development
12.19 Oncothyreon
12.19.1 Oncothyreon Corporation Information
12.19.2 Oncothyreon Business Overview
12.19.3 Oncothyreon Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.19.4 Oncothyreon Breast Cancer Therapeutics Drugs Products Offered
12.19.5 Oncothyreon Recent Development
12.20 AstraZeneca
12.20.1 AstraZeneca Corporation Information
12.20.2 AstraZeneca Business Overview
12.20.3 AstraZeneca Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.20.4 AstraZeneca Breast Cancer Therapeutics Drugs Products Offered
12.20.5 AstraZeneca Recent Development
12.21 Sprint Bioscience
12.21.1 Sprint Bioscience Corporation Information
12.21.2 Sprint Bioscience Business Overview
12.21.3 Sprint Bioscience Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.21.4 Sprint Bioscience Breast Cancer Therapeutics Drugs Products Offered
12.21.5 Sprint Bioscience Recent Development
12.22 Genentech
12.22.1 Genentech Corporation Information
12.22.2 Genentech Business Overview
12.22.3 Genentech Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.22.4 Genentech Breast Cancer Therapeutics Drugs Products Offered
12.22.5 Genentech Recent Development
12.23 Galena Biopharma
12.23.1 Galena Biopharma Corporation Information
12.23.2 Galena Biopharma Business Overview
12.23.3 Galena Biopharma Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.23.4 Galena Biopharma Breast Cancer Therapeutics Drugs Products Offered
12.23.5 Galena Biopharma Recent Development
12.24 Lycera
12.24.1 Lycera Corporation Information
12.24.2 Lycera Business Overview
12.24.3 Lycera Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.24.4 Lycera Breast Cancer Therapeutics Drugs Products Offered
12.24.5 Lycera Recent Development
12.25 CTI BioPharma
12.25.1 CTI BioPharma Corporation Information
12.25.2 CTI BioPharma Business Overview
12.25.3 CTI BioPharma Breast Cancer Therapeutics Drugs Sales, Revenue and Gross Margin (2015-2020)
12.25.4 CTI BioPharma Breast Cancer Therapeutics Drugs Products Offered
12.25.5 CTI BioPharma Recent Development
13 Breast Cancer Therapeutics Drugs Manufacturing Cost Analysis
13.1 Breast Cancer Therapeutics Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Breast Cancer Therapeutics Drugs
13.4 Breast Cancer Therapeutics Drugs Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Breast Cancer Therapeutics Drugs Distributors List
14.3 Breast Cancer Therapeutics Drugs Customers
15 Market Dynamics
15.1 Breast Cancer Therapeutics Drugs Market Trends
15.2 Breast Cancer Therapeutics Drugs Opportunities and Drivers
15.3 Breast Cancer Therapeutics Drugs Market Challenges
15.4 Breast Cancer Therapeutics Drugs Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Breast Cancer Therapeutics Drugs Sales (K MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Breast Cancer Therapeutics Drugs Sales (K MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Breast Cancer Therapeutics Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Breast Cancer Therapeutics Drugs Sales (K MT) by Region (2015-2020)
Table 5. Global Breast Cancer Therapeutics Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Breast Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Breast Cancer Therapeutics Drugs Revenue Share by Region (2015-2020)
Table 8. Global Breast Cancer Therapeutics Drugs Sales (K MT) Forecast by Region (2021-2026)
Table 9. Global Breast Cancer Therapeutics Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Breast Cancer Therapeutics Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Breast Cancer Therapeutics Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Breast Cancer Therapeutics Drugs (K MT) of Key Companies (2015-2020)
Table 13. Global Breast Cancer Therapeutics Drugs Sales Share by Company (2015-2020)
Table 14. Global Breast Cancer Therapeutics Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Breast Cancer Therapeutics Drugs Revenue Share by Company (2015-2020)
Table 16. Global Breast Cancer Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Therapeutics Drugs as of 2019)
Table 17. Global Breast Cancer Therapeutics Drugs Average Price (USD/MT) of Key Company (2015-2020)
Table 18. Manufacturers Breast Cancer Therapeutics Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Breast Cancer Therapeutics Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Breast Cancer Therapeutics Drugs Players
Table 22. Global Breast Cancer Therapeutics Drugs Sales (K MT) by Type (2015-2020)
Table 23. Global Breast Cancer Therapeutics Drugs Sales Share by Type (2015-2020)
Table 24. Global Breast Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Breast Cancer Therapeutics Drugs Price (K MT) by Type (2015-2020)
Table 26. Global Breast Cancer Therapeutics Drugs Sales Share by Type (2021-2026)
Table 27. Global Breast Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Breast Cancer Therapeutics Drugs Revenue Share by Type (2021-2026)
Table 29. Global Breast Cancer Therapeutics Drugs Price (K MT) by Type (2021-2026)
Table 30. Global Breast Cancer Therapeutics Drugs Sales (K MT) by Application (2015-2020)
Table 31. Global Breast Cancer Therapeutics Drugs Sales Share by Application (2015-2020)
Table 32. Global Breast Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Breast Cancer Therapeutics Drugs Price (K MT) by Application (2015-2020)
Table 34. Global Breast Cancer Therapeutics Drugs Sales (K MT) by Application (2021-2026)
Table 35. Global Breast Cancer Therapeutics Drugs Sales Share by Application (2021-2026)
Table 36. Global Breast Cancer Therapeutics Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Breast Cancer Therapeutics Drugs Revenue Share by Application (2021-2026)
Table 38. Global Breast Cancer Therapeutics Drugs Price (K MT) by Application (2021-2026)
Table 39. United States Breast Cancer Therapeutics Drugs Sales (K MT) by Company (2015-2020)
Table 40. United States Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Breast Cancer Therapeutics Drugs Sales (K MT) by Type (2015-2020)
Table 42. United States Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Breast Cancer Therapeutics Drugs Sales (K MT) by Application (2015-2020)
Table 44. United States Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Breast Cancer Therapeutics Drugs Sales (K MT) by Company (2015-2020)
Table 46. Europe Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Breast Cancer Therapeutics Drugs Sales (K MT) by Type (2015-2020)
Table 48. Europe Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Breast Cancer Therapeutics Drugs Sales (K MT) by Application (2015-2020)
Table 50. Europe Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 51. China Breast Cancer Therapeutics Drugs Sales (K MT) by Company (2015-2020)
Table 52. China Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 53. China Breast Cancer Therapeutics Drugs Sales (K MT) by Type (2015-2020)
Table 54. China Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 55. China Breast Cancer Therapeutics Drugs Sales (K MT) by Application (2015-2020)
Table 56. China Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Breast Cancer Therapeutics Drugs Sales (K MT) by Company (2015-2020)
Table 58. Japan Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Breast Cancer Therapeutics Drugs Sales (K MT) by Type (2015-2020)
Table 60. Japan Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Breast Cancer Therapeutics Drugs Sales (K MT) by Application (2015-2020)
Table 62. Japan Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Breast Cancer Therapeutics Drugs Sales (K MT) by Company (2015-2020)
Table 64. Southeast Asia Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Breast Cancer Therapeutics Drugs Sales (K MT) by Type (2015-2020)
Table 66. Southeast Asia Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Breast Cancer Therapeutics Drugs Sales (K MT) by Type (2015-2020)
Table 68. Southeast Asia Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 69. India Breast Cancer Therapeutics Drugs Sales (K MT) by Company (2015-2020)
Table 70. India Breast Cancer Therapeutics Drugs Sales Market Share by Company (2015-2020)
Table 71. India Breast Cancer Therapeutics Drugs Sales (K MT) by Type (2015-2020)
Table 72. India Breast Cancer Therapeutics Drugs Sales Market Share by Type (2015-2020)
Table 73. India Breast Cancer Therapeutics Drugs Sales (K MT) by Application (2015-2020)
Table 74. India Breast Cancer Therapeutics Drugs Sales Market Share by Application (2015-2020)
Table 75. Bayer HealthCare Corporation Information
Table 76. Bayer HealthCare Description and Business Overview
Table 77. Bayer HealthCare Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 78. Bayer HealthCare Breast Cancer Therapeutics Drugs Product
Table 79. Bayer HealthCare Recent Development
Table 80. Eli Lily Corporation Information
Table 81. Eli Lily Description and Business Overview
Table 82. Eli Lily Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 83. Eli Lily Breast Cancer Therapeutics Drugs Product
Table 84. Eli Lily Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 88. Pfizer Breast Cancer Therapeutics Drugs Product
Table 89. Pfizer Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 93. Novartis Breast Cancer Therapeutics Drugs Product
Table 94. Novartis Recent Development
Table 95. Eisai Corporation Information
Table 96. Eisai Description and Business Overview
Table 97. Eisai Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 98. Eisai Breast Cancer Therapeutics Drugs Product
Table 99. Eisai Recent Development
Table 100. Halozyme Therapeutics Corporation Information
Table 101. Halozyme Therapeutics Description and Business Overview
Table 102. Halozyme Therapeutics Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 103. Halozyme Therapeutics Breast Cancer Therapeutics Drugs Product
Table 104. Halozyme Therapeutics Recent Development
Table 105. Roche Corporation Information
Table 106. Roche Description and Business Overview
Table 107. Roche Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 108. Roche Breast Cancer Therapeutics Drugs Product
Table 109. Roche Recent Development
Table 110. Puma Biotechnology Corporation Information
Table 111. Puma Biotechnology Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 112. Puma Biotechnology Description and Business Overview
Table 113. Puma Biotechnology Breast Cancer Therapeutics Drugs Product
Table 114. Puma Biotechnology Recent Development
Table 115. Janssen Biotech Corporation Information
Table 116. Janssen Biotech Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 117. Janssen Biotech Description and Business Overview
Table 118. Janssen Biotech Breast Cancer Therapeutics Drugs Product
Table 119. Janssen Biotech Recent Development
Table 120. AbbVie Corporation Information
Table 121. AbbVie Description and Business Overview
Table 122. AbbVie Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 123. AbbVie Breast Cancer Therapeutics Drugs Product
Table 124. AbbVie Recent Development
Table 125. BioMarin Corporation Information
Table 126. BioMarin Description and Business Overview
Table 127. BioMarin Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 128. BioMarin Breast Cancer Therapeutics Drugs Product
Table 129. BioMarin Recent Development
Table 130. Array BioPharma Corporation Information
Table 131. Array BioPharma Description and Business Overview
Table 132. Array BioPharma Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 133. Array BioPharma Breast Cancer Therapeutics Drugs Product
Table 134. Array BioPharma Recent Development
Table 135. Merck Corporation Information
Table 136. Merck Description and Business Overview
Table 137. Merck Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 138. Merck Breast Cancer Therapeutics Drugs Product
Table 139. Merck Recent Development
Table 140. Syndax Corporation Information
Table 141. Syndax Description and Business Overview
Table 142. Syndax Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 143. Syndax Breast Cancer Therapeutics Drugs Product
Table 144. Syndax Recent Development
Table 145. MacroGenics Corporation Information
Table 146. MacroGenics Description and Business Overview
Table 147. MacroGenics Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 148. MacroGenics Breast Cancer Therapeutics Drugs Product
Table 149. MacroGenics Recent Development
Table 150. ImmunoGen Corporation Information
Table 151. ImmunoGen Description and Business Overview
Table 152. ImmunoGen Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 153. ImmunoGen Breast Cancer Therapeutics Drugs Product
Table 154. ImmunoGen Recent Development
Table 155. Santen Pharma Corporation Information
Table 156. Santen Pharma Description and Business Overview
Table 157. Santen Pharma Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 158. Santen Pharma Breast Cancer Therapeutics Drugs Product
Table 159. Santen Pharma Recent Development
Table 160. Celgene Corporation Information
Table 161. Celgene Description and Business Overview
Table 162. Celgene Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 163. Celgene Breast Cancer Therapeutics Drugs Product
Table 164. Celgene Recent Development
Table 165. Oncothyreon Corporation Information
Table 166. Oncothyreon Description and Business Overview
Table 167. Oncothyreon Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 168. Oncothyreon Breast Cancer Therapeutics Drugs Product
Table 169. Oncothyreon Recent Development
Table 170. AstraZeneca Corporation Information
Table 171. AstraZeneca Description and Business Overview
Table 172. AstraZeneca Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 173. AstraZeneca Breast Cancer Therapeutics Drugs Product
Table 174. AstraZeneca Recent Development
Table 175. Sprint Bioscience Corporation Information
Table 176. Sprint Bioscience Description and Business Overview
Table 177. Sprint Bioscience Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 178. Sprint Bioscience Breast Cancer Therapeutics Drugs Product
Table 179. Sprint Bioscience Recent Development
Table 180. Genentech Corporation Information
Table 181. Genentech Description and Business Overview
Table 182. Genentech Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 183. Genentech Breast Cancer Therapeutics Drugs Product
Table 184. Genentech Recent Development
Table 185. Galena Biopharma Corporation Information
Table 186. Galena Biopharma Description and Business Overview
Table 187. Galena Biopharma Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 188. Galena Biopharma Breast Cancer Therapeutics Drugs Product
Table 189. Galena Biopharma Recent Development
Table 190. Lycera Corporation Information
Table 191. Lycera Description and Business Overview
Table 192. Lycera Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 193. Lycera Breast Cancer Therapeutics Drugs Product
Table 194. Lycera Recent Development
Table 195. CTI BioPharma Corporation Information
Table 196. CTI BioPharma Description and Business Overview
Table 197. CTI BioPharma Breast Cancer Therapeutics Drugs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2015-2020)
Table 198. CTI BioPharma Breast Cancer Therapeutics Drugs Product
Table 199. CTI BioPharma Recent Development
Table 200. Production Base and Market Concentration Rate of Raw Material
Table 201. Key Suppliers of Raw Materials
Table 202. Breast Cancer Therapeutics Drugs Distributors List
Table 203. Breast Cancer Therapeutics Drugs Customers List
Table 204. Breast Cancer Therapeutics Drugs Market Key Trends
Table 205. Breast Cancer Therapeutics Drugs Key Opportunities and Drivers
Table 206. Breast Cancer Therapeutics Drugs Market Challenges
Table 207. Research Programs/Design for This Report
Table 208. Key Data Information from Secondary Sources
Table 209. Key Data Information from Primary Sources
List of Figures
Figure 1. Breast Cancer Therapeutics Drugs Product Picture
Figure 2. Global Breast Cancer Therapeutics Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Breast Cancer Therapeutics Drugs Market Share by Application in 2020 & 2026
Figure 6. Phase I Examples
Figure 7. Phase II Examples
Figure 8. Phase III Examples
Figure 9. Global Breast Cancer Therapeutics Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 10. Global Breast Cancer Therapeutics Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Breast Cancer Therapeutics Drugs Price Trends Growth Rate (2015-2026) (USD/MT)
Figure 12. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Breast Cancer Therapeutics Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Breast Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Breast Cancer Therapeutics Drugs Sales (K MT) Growth Rate (2015-2026)
Figure 16. Europe Breast Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Breast Cancer Therapeutics Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Breast Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Breast Cancer Therapeutics Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Breast Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Breast Cancer Therapeutics Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Breast Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Breast Cancer Therapeutics Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Breast Cancer Therapeutics Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Breast Cancer Therapeutics Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Breast Cancer Therapeutics Drugs Players Market Share by Revenue in Breast Cancer Therapeutics Drugs 2015 & 2019
Figure 27. Breast Cancer Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Breast Cancer Therapeutics Drugs Revenue Share by Type (2015-2020)
Figure 29. Global Breast Cancer Therapeutics Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Breast Cancer Therapeutics Drugs Revenue Share by Application (2015-2020)
Figure 31. Global Breast Cancer Therapeutics Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Breast Cancer Therapeutics Drugs Sales Market Share by Type in 2019
Figure 33. United States Breast Cancer Therapeutics Drugs Sales Market Share by Type in 2019
Figure 34. Europe Breast Cancer Therapeutics Drugs Sales Market Share by Company in 2019
Figure 35. Europe Breast Cancer Therapeutics Drugs Sales Market Share by Type in 2019
Figure 36. Europe Breast Cancer Therapeutics Drugs Sales Market Share by Application in 2019
Figure 37. China Breast Cancer Therapeutics Drugs Sales Market Share by Company in 2019
Figure 38. China Breast Cancer Therapeutics Drugs Sales Market Share by Type in 2019
Figure 39. China Breast Cancer Therapeutics Drugs Sales Market Share by Application in 2019
Figure 40. Japan Breast Cancer Therapeutics Drugs Sales Market Share by Company in 2019
Figure 41. Japan Breast Cancer Therapeutics Drugs Sales Market Share by Type in 2019
Figure 42. Japan Breast Cancer Therapeutics Drugs Sales Market Share by Application in 2019
Figure 43. Southeast Asia Breast Cancer Therapeutics Drugs Sales Market Share by Company in 2019
Figure 44. Southeast Asia Breast Cancer Therapeutics Drugs Sales Market Share by Type in 2019
Figure 45. Southeast Asia Breast Cancer Therapeutics Drugs Sales Market Share by Application in 2019
Figure 46. India Breast Cancer Therapeutics Drugs Sales Market Share by Company in 2019
Figure 47. India Breast Cancer Therapeutics Drugs Sales Market Share by Type in 2019
Figure 48. India Breast Cancer Therapeutics Drugs Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Breast Cancer Therapeutics Drugs
Figure 51. Manufacturing Process Analysis of Breast Cancer Therapeutics Drugs
Figure 52. Breast Cancer Therapeutics Drugs Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
泌尿器がん治療薬の世界市場レポート2020 Global Urological Cancer Therapeutics Drugs Market is estimated to reach $48.6 billion by 2025 Says, .Now a days urological cancers became very common worldwide and causing higher mortality rates. Specially in the case of kidney cancers, that illustrates the new therapeutic targets. Urological cance…- がんCDK阻害剤の世界市場レポート2020 Market Analysis and Insights: Global Cancer CDK Inhibitors Market The global Cancer CDK Inhibitors market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Cancer CDK Inhibitors Scope and Market Size The global Cancer CDK Inhibi…
- トレプロスチニル薬の世界市場レポート2020 Treprostinil is a vasodilator that is used for the treatment of pulmonary arterial hypertension. North America is the largest consumption place, with a consumption market share nearly 92% in 2018. Following North America, Europe are also very important market with the consumption market share of 6.8…
- CINV（化学療法に伴う悪心・嘔吐）治療薬の世界市場レポート2020 Chemotherapy-induced nausea and vomiting (CINV) is a common side-effect of many cancer treatments. Nausea and vomiting are two of the most feared cancer treatment-related side effects for cancer patients and their families. The classification of Chemotherapy Induced Nausea and Vomiting (CINV) Drugs …
- 多発性硬化症（MS）治療薬の世界市場レポート2020 Market Analysis and Insights: Global Multiple Sclerosis (MS) Drugs Market The global Multiple Sclerosis (MS) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Multiple Sclerosis (MS) Drugs Scope and Market Size The …